|
contents | europe | ||||
| BioPartnering Europe 2006 Technology Vision Group LLC is pleased to announce that as BPE entered its 14th year, it continued to stand out as the top European Biotech conference for partnering and business opportunities. The 15th Annual BioPartnering Europe will be held on October 7-9, 2007 in London. This year there were well over 2500 meetings scheduled via the biopartnering.com software, with numerous other ad hoc meetings over the course of the two days. Dr Ulf Boberg, CEO of Affibody, commented, "Presenting Affibody in an Open House session proved to be a very effective platform for us to showcase our business enabling us to develop a range of promising discussions with leading players in the life science industry." As usual the BioPartnering Leadership sessions provided some interesting and lively discussion and insights into the current issues facing the biotech industry. One of these sessions entitled, "Strategic Deals That Create Value" saw an expert panel analyze and discuss several interesting structures that have been used by bioscience companies to achieve successful strategic deals that retain value, including indication-splitting deals, partnering by territories, "reverse-partnering" (pharma outlicensing), and spin-out transactions. The panel also discussed changes to the traditional collaboration structure whereby big pharma companies have to compete with larger biotech firms for licensing opportunities, giving biotech companies more negotiating power and better deals in the process. write your comments about the article :: © 2006 Exhibition News :: home page |